Sanofi-Aventis Loses Patent Lawsuit In Korea Over Oxaliplatin

SHANGHAI - Sanofi-Aventis lost a patent lawsuit in South Korea, after the country's Supreme Court dismissed its appeal to nullify patents obtained by Korea-based Boryung Pharmaceutical for its generic drug for colorectal cancer, Boryung announced Oct. 20